BRIEF published on 11/20/2025 at 17:50, 14 days 11 hours ago Mauna Kea's Cellvizio Gen 3 receives approval in China NMPA Approval Chinese Market Mauna Kea Cellvizio Gen 3 Endoscopy
PRESS RELEASE published on 11/20/2025 at 17:45, 14 days 11 hours ago Inside Information / Other news releases Mauna Kea Technologies obtains NMPA approval in China for Cellvizio Gen 3 platform, aiming to commercialize independently. Approval valid until November 2030, reinforcing company's assets in China NMPA Approval China Commercialization Mauna Kea Technologies Cellvizio Gen 3 Platform
BRIEF published on 11/14/2025 at 07:50, 20 days 21 hours ago Mauna Kea Technologies: Successful Financial Restructuring Capital Increase Restructuring Debt Reduction Mauna Kea Technologies Financial Visibility
PRESS RELEASE published on 11/14/2025 at 07:45, 20 days 21 hours ago Inside Information / Other news releases Mauna Kea Technologies successfully completes financial restructuring and €6M capital raise, reducing debt, securing financial visibility, and enhancing equity. Paris and Boston - Nov 14, 2025 Debt Reduction Financial Restructuring Capital Raise Equity Increase Mauna Kea Technologies
BRIEF published on 11/13/2025 at 07:50, 21 days 21 hours ago Mauna Kea Technologies Resumes Trading with €5M Capital Raise Financial Strategy Paris Commercial Court Retail Investment Capital Raise Safeguard Plan
PRESS RELEASE published on 11/13/2025 at 07:45, 21 days 21 hours ago Inside Information / Other news releases Mauna Kea Technologies exits safeguard proceedings after Paris Commercial Court's approval of the Plan, initiating a minimum €5M capital raise. CEO Sacha Loiseau commits €100,000 to capital increase Paris Commercial Court Capital Raise Mauna Kea Technologies Safeguard Proceedings CEO Sacha Loiseau
BRIEF published on 10/21/2025 at 17:50, 1 month 14 days ago Mauna Kea Technologies secures €5 million for its capital increase Investors Capital Increase Backup Plan Mauna Kea Profitability 2027
BRIEF published on 10/08/2025 at 17:50, 1 month 27 days ago Mauna Kea Technologies: Details of the Capital Increase Investors Profitability Capital Increase Backup Plan Mauna Kea Technologies
BRIEF published on 09/18/2025 at 17:55, 2 months 16 days ago Mauna Kea and Endotherapeutics Introduce Cellvizio to Australia Global Expansion Medical Technology Cellvizio Food Intolerances Australia Launch
PRESS RELEASE published on 09/18/2025 at 17:50, 2 months 16 days ago Inside Information / Other news releases Mauna Kea Technologies and Endotherapeutics secure first Australian orders for Cellvizio system, expanding commercial presence with CellTolerance indication, paving the way for global market growth Australia Mauna Kea Technologies CellTolerance Endotherapeutics Cellvizio System
Published on 12/05/2025 at 02:35, 2 hours 47 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 22 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 17 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 22 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 51 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 31 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 56 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 7 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 11 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 22 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 37 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 38 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 21 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
